T. Rowe Price Associates’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-568,370
Closed -$34.3M 2633
2016
Q2
$34.3M Sell
568,370
-829
-0.1% -$47K 0.01% 910
2016
Q1
$26.2M Buy
569,199
+2,032
+0.4% +$73.7K 0.01% 990
2015
Q4
$27.4M Sell
567,167
-34,034
-6% -$1.47M 0.01% 987
2015
Q3
$25.6M Buy
601,201
+38,707
+7% +$1.92M 0.01% 1008
2015
Q2
$32.1M Buy
562,494
+262,360
+87% +$16.2M 0.01% 985
2015
Q1
$19.4M Buy
300,134
+138,200
+85% +$7.92M ﹤0.01% 1142
2014
Q4
$8.06M Sell
161,934
-13,136
-8% -$683K ﹤0.01% 1378
2014
Q3
$8.65M Sell
175,070
-8,670
-5% -$368K ﹤0.01% 1341
2014
Q2
$7.08M Buy
183,740
+9,224
+5% +$311K ﹤0.01% 1390
2014
Q1
$5.62M Sell
174,516
-3,484
-2% -$129K ﹤0.01% 1415
2013
Q4
$5.68M Sell
178,000
-3,944,200
-96% -$119M ﹤0.01% 1414
2013
Q3
$124M Buy
4,122,200
+764,600
+23% +$21.8M 0.03% 528
2013
Q2
$82.6M Buy
+3,357,600
New +$84.5M 0.02% 629

Other funds holding MDVN

T. Rowe Price Associates's MDVN Position: Q3 2016 in Review

T. Rowe Price Associates sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 568,370 shares — an estimated $34.3M sold.

T. Rowe Price Associates first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $124M in Q3 2013. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • T. Rowe Price Associates reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 568,370 MEDIVATION, INC. shares in Q3 2016, an estimated $34.3M.
  • T. Rowe Price Associates first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • T. Rowe Price Associates's MEDIVATION, INC. position peaked at $124M in Q3 2013.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.